UPDATE: Benchmark Raises Price Target on BioClinica to $8

According to Benchmark, BioClinica BIOC price target is raised to $8. Benchmark said that it hosted an investor event at BioClinica's eClinical software headquarters in Audubon, PA on January 13. “We are increasing our price target to $8.00, from $7.00, to reflect a 20x multiple of our unchanged $0.40 EPS forecast this year.” BioClinica closed on Friday at $4.77.